HALO—Interim update on phase-2 ‘202’ trial in pancreatic cancer from Fred Hutchinson newsletter: http://www.fredhutch.org/en/news/center-news/2015/05/enzyme-doubles-survival-in-pancreas-cancer-patients.html HALO’s own PR: http://finance.yahoo.com/news/halozyme-phase-2-clinical-study-151500758.html